Butler John P.

CEO and President at AKBA; Director at Zynerba Pharmaceuticals, Inc.; Director at Relypsa Inc

Sold, on record
$1.6M
Dollars the filings state
Form 4 sales
15
Latest Feb 2, 2026
Form 144 notices
5
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale AKBANo plan
    Feb 27, 2024 2024

    Sold 37,733 shares at $1.52 ($57k)

    Butler John P., CEO and President

    No 10b5-1 planSold 1.8% of holdings ($3.2M position)2.1M shares left0.6x usual sizeFollows a Form 144Filing

  2. 2 Form 144 notice AKBANotice
    Feb 29, 2024 +2 days

    Filed to sell 46,570 shares ($73k)

    Butler John P., Officer, Director

    No 10b5-1 plan1x usual sizeFiling

  3. 3 Form 4 sale AKBANo plan
    Feb 29, 2024 same day

    Sold 46,570 shares at $1.58 ($74k)

    Butler John P., CEO and President

    No 10b5-1 planSold 2.2% of holdings ($3.3M position)2M shares left1.1x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice AKBANotice
    Feb 3, 2025 +340 days

    Filed to sell 144,250 shares ($304k)

    Butler John P., Officer, Director

    No 10b5-1 plan3.1x usual sizeFiling

  5. 5 Form 4 sale AKBAUnusual
    Feb 3, 2025 same day

    Sold 144,250 shares at $2.10 ($303k)

    Butler John P., CEO and President

    10b5-1 planSold 5.2% of holdings ($5.8M position)2.6M shares left3.1x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice AKBANotice
    Mar 3, 2025 +28 days

    Filed to sell 46,409 shares ($85k)

    Butler John P., Officer, Director

    No 10b5-1 plan1x usual sizeFiling

  7. 7 Form 4 sale AKBARoutine
    Mar 3, 2025 same day

    Sold 46,409 shares at $1.83 ($85k)

    Butler John P., CEO and President

    10b5-1 planSold 1.8% of holdings ($4.8M position)2.6M shares left1x usual sizeFollows a Form 144Filing

  8. 8 Form 4 sale AKBAUnusual
    Feb 2, 2026 +336 days

    Sold 341,305 shares at $1.39 ($474k)

    Butler John P., CEO and President

    10b5-1 planSold 9.4% of holdings ($5.1M position)3.3M shares left7.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (20)

Form 144 notices and Form 4 sales by Butler John P.
Source
Feb 2, 2026Feb 4, 2026AKBACEO and PresidentForm 4 sale341,305$474k9.4%UnusualSEC
Mar 3, 2025Mar 4, 2025AKBACEO and PresidentForm 4 sale46,409$85k1.8%RoutineSEC
Mar 3, 2025Mar 3, 2025AKBAOfficer, DirectorForm 144 notice46,409$85kNoticeSEC
Feb 3, 2025Feb 4, 2025AKBACEO and PresidentForm 4 sale144,250$303k5.2%UnusualSEC
Feb 3, 2025Feb 3, 2025AKBAOfficer, DirectorForm 144 notice144,250$304kNoticeSEC
Feb 29, 2024Mar 1, 2024AKBACEO and PresidentForm 4 sale46,570$74k2.2%No planSEC
Feb 29, 2024Feb 29, 2024AKBAOfficer, DirectorForm 144 notice46,570$73kNoticeSEC
Feb 27, 2024Feb 29, 2024AKBACEO and PresidentForm 4 sale37,733$57k1.8%No planSEC
Feb 27, 2024Feb 27, 2024AKBAOfficer, DirectorForm 144 notice37,733$57kNoticeSEC
Feb 1, 2024Feb 2, 2024AKBACEO and PresidentForm 4 sale46,489$78k2.1%No planSEC
Feb 1, 2024Feb 1, 2024AKBAOfficer, DirectorForm 144 notice46,489$78kNoticeSEC
Jun 14, 2023Jun 15, 2023Zynerba Pharmaceuticals, Inc.DirectorForm 4 sale115$400.1%No planSEC
Mar 1, 2023Mar 3, 2023AKBACEO and PresidentForm 4 sale91,868$81k5.5%Plan not statedSEC
Feb 27, 2023Mar 1, 2023AKBACEO and PresidentForm 4 sale38,632$31k2.3%Plan not statedSEC
Jun 14, 2022Jun 16, 2022Zynerba Pharmaceuticals, Inc.DirectorForm 4 sale53$540.2%Plan not statedSEC
Mar 1, 2022Mar 2, 2022AKBACEO and PresidentForm 4 sale79,026$171k5.3%Plan not statedSEC
Apr 1, 2021Apr 1, 2021AKBACEO and PresidentForm 4 sale4,109$14k0.4%Plan not statedSEC
Mar 1, 2021Mar 2, 2021AKBACEO and PresidentForm 4 sale49,990$170k4.3%Plan not statedSEC
Jun 7, 2016Jun 8, 2016Relypsa IncDirectorForm 4 sale1,013$20k26.2%UnusualSEC
Jun 11, 2015Jun 15, 2015Relypsa IncDirectorForm 4 sale1,100$38k22.2%Plan not statedSEC